<VariationArchive VariationID="180663" VariationName="NM_002582.3(PARN):c.[659+4_659+7delAGTA(;)863dupA]" VariationType="Phase unknown" Accession="VCV000180663" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2015-03-24" MostRecentSubmission="2015-03-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Haplotype VariationID="180663" NumberOfChromosomes="1">
      <SimpleAllele AlleleID="178829" VariationID="190290">
        <GeneList>
          <Gene Symbol="PARN" FullName="poly(A)-specific ribonuclease" GeneID="5073" HGNC_ID="HGNC:8609" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>16p13.12</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="14435701" stop="14630260" display_start="14435701" display_stop="14630260" Strand="-" />
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NT_187607.1" start="8558" stop="203161" display_start="8558" display_stop="203161" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="14529556" stop="14724127" display_start="14529556" display_stop="14724127" Strand="-" />
            </Location>
            <OMIM>604212</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_002582.4(PARN):c.863dup (p.Asn288fs)</Name>
        <CanonicalSPDI>NC_000016.10:14593355:TT:TTT</CanonicalSPDI>
        <VariantType>Duplication</VariantType>
        <Location>
          <CytogeneticLocation>16p13.12</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="14593355" stop="14593356" display_start="14593355" display_stop="14593356" variantLength="1" positionVCF="14593355" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="14687212" stop="14687213" display_start="14687212" display_stop="14687213" variantLength="1" positionVCF="14687212" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        </Location>
        <ProteinChange>N242fs</ProteinChange>
        <ProteinChange>N288fs</ProteinChange>
        <ProteinChange>N227fs</ProteinChange>
        <HGVSlist>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_1286" sequenceAccession="LRG_1286" change="g.41916dup">
              <Expression>LRG_1286:g.41916dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_1286t1" sequenceAccession="LRG_1286t1" change="c.863dup">
              <Expression>LRG_1286t1:c.863dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_1286p1" sequenceAccession="LRG_1286p1" change="p.Asn288fs">
              <Expression>LRG_1286p1:p.Asn288fs</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.14593357dup" Assembly="GRCh38">
              <Expression>NC_000016.10:g.14593357dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.14687214dup" Assembly="GRCh37">
              <Expression>NC_000016.9:g.14687214dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_042871.1" sequenceAccession="NG_042871" sequenceVersion="1" change="g.41916dup">
              <Expression>NG_042871.1:g.41916dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001134477.3" sequenceAccession="NM_001134477" sequenceVersion="3" change="c.680dup">
              <Expression>NM_001134477.3:c.680dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001127949.1" sequenceAccession="NP_001127949" sequenceVersion="1" change="p.Asn227fs">
              <Expression>NP_001127949.1:p.Asn227fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001242992.2" sequenceAccession="NM_001242992" sequenceVersion="2" change="c.725dup">
              <Expression>NM_001242992.2:c.725dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001229921.1" sequenceAccession="NP_001229921" sequenceVersion="1" change="p.Asn242fs">
              <Expression>NP_001229921.1:p.Asn242fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_002582.4" sequenceAccession="NM_002582" sequenceVersion="4" change="c.863dup" MANESelect="true">
              <Expression>NM_002582.4:c.863dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_002573.1" sequenceAccession="NP_002573" sequenceVersion="1" change="p.Asn288fs">
              <Expression>NP_002573.1:p.Asn288fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2015-05-01" DateCreated="2015-05-14" MostRecentSubmission="2019-08-03" NumberOfSubmissions="1" NumberOfSubmitters="1">
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">25893599</ID>
            </Citation>
            <ConditionList>
              <TraitSet ID="21497" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="33330" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal recessive 6</ElementValue>
                    <XRef ID="MONDO:0014600" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">DKCB6</ElementValue>
                    <XRef Type="MIM" ID="616353" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                    <XRef ID="NBK22301" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="16095" />
                    <XRef ID="16095" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301779</ID>
                    <ID Source="BookShelf">NBK22301</ID>
                  </Citation>
                  <XRef ID="C4225356" DB="MedGen" />
                  <XRef ID="MONDO:0014600" DB="MONDO" />
                  <XRef Type="MIM" ID="616353" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA250322" DB="ClinGen" />
          <XRef Type="Allelic variant" ID="604212.0003" DB="OMIM" />
          <XRef Type="rs" ID="786201001" DB="dbSNP" />
          <XRef Type="Interpreted" ID="180663" DB="ClinVar" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="178830" VariationID="190291">
        <GeneList>
          <Gene Symbol="PARN" FullName="poly(A)-specific ribonuclease" GeneID="5073" HGNC_ID="HGNC:8609" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>16p13.12</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="14435701" stop="14630260" display_start="14435701" display_stop="14630260" Strand="-" />
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NT_187607.1" start="8558" stop="203161" display_start="8558" display_stop="203161" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="14529556" stop="14724127" display_start="14529556" display_stop="14724127" Strand="-" />
            </Location>
            <OMIM>604212</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_002582.4(PARN):c.659+4_659+7del</Name>
        <CanonicalSPDI>NC_000016.10:14608273:TACTTACTT:TACTT</CanonicalSPDI>
        <VariantType>Microsatellite</VariantType>
        <Location>
          <CytogeneticLocation>16p13.12</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="14608274" stop="14608277" display_start="14608274" display_stop="14608277" variantLength="4" positionVCF="14608273" referenceAlleleVCF="ATACT" alternateAlleleVCF="A" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="14702131" stop="14702134" display_start="14702131" display_stop="14702134" variantLength="4" positionVCF="14702130" referenceAlleleVCF="ATACT" alternateAlleleVCF="A" />
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.14608275ACTT[1]" Assembly="GRCh38">
              <Expression>NC_000016.10:g.14608275ACTT[1]</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.14702132ACTT[1]" Assembly="GRCh37">
              <Expression>NC_000016.9:g.14702132ACTT[1]</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_042871.1" sequenceAccession="NG_042871" sequenceVersion="1" change="g.26991AGTA[1]">
              <Expression>NG_042871.1:g.26991AGTA[1]</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001134477.3" sequenceAccession="NM_001134477" sequenceVersion="3" change="c.476+4_476+7del">
              <Expression>NM_001134477.3:c.476+4_476+7del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001242992.2" sequenceAccession="NM_001242992" sequenceVersion="2" change="c.521+4_521+7del">
              <Expression>NM_001242992.2:c.521+4_521+7del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_002582.4" sequenceAccession="NM_002582" sequenceVersion="4" change="c.659+4_659+7del" MANESelect="true">
              <Expression>NM_002582.4:c.659+4_659+7del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_1286" sequenceAccession="LRG_1286">
              <Expression>LRG_1286:g.26991AGTA[1]</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_1286t1" sequenceAccession="LRG_1286t1">
              <Expression>LRG_1286t1:c.659+4_659+7del</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-01-18" DateCreated="2015-05-14" MostRecentSubmission="2024-02-25" NumberOfSubmissions="3" NumberOfSubmitters="3">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Uncertain significance</Description>
            <Citation Type="general">
              <ID Source="PubMed">17576681</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25893599</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">9536098</ID>
            </Citation>
            <DescriptionHistory Dated="2023-02-02">
              <Description>Pathogenic</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="21497" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="33330" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal recessive 6</ElementValue>
                    <XRef ID="MONDO:0014600" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">DKCB6</ElementValue>
                    <XRef Type="MIM" ID="616353" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                    <XRef ID="NBK22301" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="16095" />
                    <XRef ID="16095" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301779</ID>
                    <ID Source="BookShelf">NBK22301</ID>
                  </Citation>
                  <XRef ID="C4225356" DB="MedGen" />
                  <XRef ID="MONDO:0014600" DB="MONDO" />
                  <XRef Type="MIM" ID="616353" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="36521" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="33330" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal recessive 6</ElementValue>
                    <XRef ID="MONDO:0014600" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">DKCB6</ElementValue>
                    <XRef Type="MIM" ID="616353" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                    <XRef ID="NBK22301" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="16095" />
                    <XRef ID="16095" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301779</ID>
                    <ID Source="BookShelf">NBK22301</ID>
                  </Citation>
                  <XRef ID="C4225356" DB="MedGen" />
                  <XRef ID="MONDO:0014600" DB="MONDO" />
                  <XRef Type="MIM" ID="616353" DB="OMIM" />
                </Trait>
                <Trait ID="33357" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4</ElementValue>
                    <XRef ID="MONDO:0014612" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 4</ElementValue>
                    <XRef Type="MIM" ID="616371" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="604212.0005" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="604212.0008" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="604212.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="604212.0007" DB="OMIM" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">PFBMFT4</ElementValue>
                    <XRef Type="MIM" ID="616371" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="16097" />
                    <XRef ID="16097" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                    <XRef ID="NBK22301" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301408</ID>
                    <ID Source="BookShelf">NBK1230</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301779</ID>
                    <ID Source="BookShelf">NBK22301</ID>
                  </Citation>
                  <XRef ID="2032" DB="Orphanet" />
                  <XRef ID="C4225347" DB="MedGen" />
                  <XRef ID="MONDO:0014612" DB="MONDO" />
                  <XRef Type="MIM" ID="616371" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA250323" DB="ClinGen" />
          <XRef Type="Allelic variant" ID="604212.0004" DB="OMIM" />
          <XRef Type="rs" ID="759131762" DB="dbSNP" />
          <XRef Type="Interpreted" ID="180663" DB="ClinVar" />
        </XRefList>
      </SimpleAllele>
      <Name>NM_002582.3(PARN):c.[659+4_659+7delAGTA(;)863dupA]</Name>
      <VariationType>Phase unknown</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_002582.3:c.[659+4_659+7delAGTA(;)863dupA]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Haplotype>
    <RCVList>
      <RCVAccession Title="NM_002582.3(PARN):c.[659+4_659+7delAGTA(;)863dupA] AND Dyskeratosis congenita" Accession="RCV000162315" Version="2">
        <ClassifiedConditionList TraitSetID="8154">
          <ClassifiedCondition DB="MedGen" ID="C0265965">Dyskeratosis congenita</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-02-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-02-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-03-24" MostRecentSubmission="2015-03-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25893599</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8154" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15989" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita</ElementValue>
                <XRef ID="Dyskeratosis+congenita/9566" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015780" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
                <XRef ID="74911008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10905" />
                <XRef ID="10905" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="1775" DB="Orphanet" />
              <XRef ID="C0265965" DB="MedGen" />
              <XRef ID="MONDO:0015780" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="373055" SubmissionDate="2015-02-04" DateLastUpdated="2015-03-24" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="DC3068|MedGen:78580" />
        <ClinVarAccession Accession="SCV000206799" DateUpdated="2015-03-24" DateCreated="2015-03-24" Type="SCV" Version="1" SubmitterName="Bone Marrow Failure laboratory, Queen Mary University London" OrgID="505354" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-02-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1">
                <FamilyHistory>no</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Haplotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="PARN" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_002582.3:c.659+4_659+7delAGTA</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="PARN" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_002582.3:c.863dupA</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <Name>NM_002582.3:c.[659+4_659+7delAGTA(;)863dupA]</Name>
        </Haplotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Dyskeratosis congenita</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0265965" Type="CUI" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="373055" TraitType="Disease" MappingType="Name" MappingValue="Dyskeratosis congenita" MappingRef="Preferred">
        <MedGen CUI="C0265965" Name="Dyskeratosis congenita" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

